Haratipour Zeinab, Foutch David, Blind Raymond D
Vanderbilt University Medical Center, Department of Medicine, Division of Diabetes, Endocrinology and Metabolism, Nashville, TN 37232, USA.
Austin Peay State University, Department of Chemistry.
Comput Struct Biotechnol J. 2024 Jul 30;23:3065-3080. doi: 10.1016/j.csbj.2024.07.021. eCollection 2024 Dec.
The nuclear receptor Liver Receptor Homolog-1 (LRH-1, ) is a ligand-regulated transcription factor and validated drug target for several human diseases. LRH-1 activation is regulated by small molecule ligands, which bind to the ligand binding domain (LBD) within the full-length LRH-1. We recently identified 57 compounds that bind LRH-1, and unexpectedly found these compounds regulated either the isolated LBD, or the full-length LRH-1 in cells, with little overlap. Here, we correlated compound binding energy from a single rigid-body scoring function with full-length LRH-1 activity in cells. Although docking scores of the 57 hit compounds did not correlate with LRH-1 regulation in wet lab assays, a subset of the compounds had large differences in binding energy docked to the isolated LBD . full-length LRH-1, which we used to empirically derive a new metric of the docking scores we call "ΔΔG". Initial regressions, correlations and contingency analyses all suggest compounds with high ΔΔG values more frequently regulated LRH-1 in wet lab assays. We then docked all 57 compounds to 18 separate crystal structures of LRH-1 to obtain averaged ΔΔG values for each compound, which robustly and reproducibly associated with full-length LRH-1 activity in cells. Network analyses on the 18 crystal structures of LRH-1 suggest unique communication paths exist between the subsets of LRH-1 crystal structures that produced high low ΔΔG values, identifying a structural relationship between ΔΔG and the position of Helix 6, a previously established regulatory helix important for LRH-1 regulation. Together, these data suggest rigid-body computational docking can be used to quickly calculate ΔΔG, which positively correlated with the ability of these 57 hit compounds to regulate full-length LRH-1 in cell-based assays. We propose ΔΔG as a novel computational tool that can be applied to LRH-1 drug screens to prioritize compounds for resource-intense secondary screening.
核受体肝受体同源物-1(LRH-1)是一种配体调节的转录因子,也是多种人类疾病的已验证药物靶点。LRH-1的激活受小分子配体调节,这些配体与全长LRH-1内的配体结合域(LBD)结合。我们最近鉴定出57种与LRH-1结合的化合物,并意外发现这些化合物要么调节分离的LBD,要么调节细胞中的全长LRH-1,几乎没有重叠。在这里,我们将来自单一刚体评分函数的化合物结合能与细胞中全长LRH-1的活性相关联。尽管这57种命中化合物的对接分数与湿实验室测定中的LRH-1调节不相关,但其中一部分化合物对接至分离的LBD和全长LRH-1时的结合能有很大差异,我们利用这些差异凭经验得出了一种新的对接分数度量,我们称之为“ΔΔG”。初步回归、相关性和列联分析均表明,在湿实验室测定中,具有高ΔΔG值的化合物更频繁地调节LRH-1。然后,我们将所有57种化合物对接至LRH-